Akari Therapeutics (AKTX) Stock Chart & Stock Price History $0.98 -0.07 (-6.64%) Closing price 02/21/2025 03:54 PM EasternExtended Trading$0.98 -0.01 (-0.51%) As of 02/21/2025 05:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends Akari Therapeutics Stock Price Performance 5 Day Performance-9.13%1 Month Performance-21.83%3 Month Performance-24.23%6 Month Performance-73.38%Year-To-Date Performance-19.26%1 Year Performance-56.03% Receive AKTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address AKTX Stock Chart for Saturday, February, 22, 2025 AKTX Chart by TradingView Akari Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$1.06$0.99-6.64%$1.05$0.9529,967 shs$26.07 million02/20/2025$1.07$1.06-1.40%$1.08$1.044,699 shs$27.93 million02/19/2025$1.01$1.07+5.94%$1.07$1.0117,144 shs$28.32 million02/18/2025$1.08$1.01-6.83%$1.09$1.0073,943 shs$26.74 million02/17/2025$1.08$1.08$1.11$1.0614,566 shs$28.69 million02/14/2025$1.09$1.08-0.09%$1.11$1.0614,566 shs$28.69 million02/13/2025$1.13$1.09-3.90%$1.13$1.0637,485 shs$28.72 million02/12/2025$1.10$1.13+2.64%$1.19$1.0610,872 shs$29.89 million02/11/2025$1.12$1.10-2.14%$1.33$1.1036,932 shs$29.12 million02/10/2025$1.29$1.12-12.53%$1.30$1.1244,478 shs$29.76 million Get the Latest News and Ratings for AKTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$1.25$1.29+2.80%$1.30$1.226,589 shs$34.01 million02/06/2025$1.14$1.25+9.65%$1.35$1.1234,409 shs$33.09 million02/05/2025$1.17$1.14-2.56%$1.27$1.1047,706 shs$30.18 million02/04/2025$1.20$1.17-2.58%$1.25$1.1510,468 shs$30.97 million02/03/2025$1.09$1.20+10.18%$1.30$1.1087,431 shs$31.79 million01/31/2025$1.35$1.09-19.26%$1.39$1.0781,023 shs$28.85 million01/30/2025$1.35$1.35+0.33%$1.38$1.317,792 shs$35.73 million01/29/2025$1.33$1.35+1.17%$1.40$1.3515,559 shs$35.62 million01/28/2025$1.29$1.33+3.10%$1.35$1.1821,578 shs$35.21 million01/27/2025$1.21$1.29+6.70%$1.32$1.1322,315 shs$34.15 million01/24/2025$1.20$1.21+0.75%$1.28$1.149,927 shs$32.00 million01/23/2025$1.26$1.20-4.76%$1.22$1.188,715 shs$31.76 million01/22/2025$1.26$1.26+0.40%$1.29$1.2132,371 shs$33.35 million01/21/2025$1.21$1.26+4.15%$1.31$1.1611,154 shs$33.22 million Related Companies BioXcel Therapeutics Stock Chart Editas Medicine Stock Chart Coya Therapeutics Stock Chart Vigil Neuroscience Stock Chart Journey Medical Stock Chart TScan Therapeutics Stock Chart Artiva Biotherapeutics Stock Chart Procaps Group Stock Chart Rani Therapeutics Stock Chart Atossa Therapeutics Stock Chart Receive AKTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AKTX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akari Therapeutics, Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Akari Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AKTX Stock Alerts